NEW DRUGS IN JAPAN

被引：0
|
作者：
OGAWA, M [1 ]
机构：
[1] JAPANESE FDN CANC RES,CTR CANC CHEMOTHERAPY,TOKYO 170,JAPAN
来源：
INVESTIGATIONAL NEW DRUGS | 1984年 / 2卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [21] Development of new anticancer drugs - The historical background and current status in Japan
    Tsukagoshi, S
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1997, 117 (10-11): : 875 - 883
  • [22] Japan Works To Shorten "Drug Lag," Boost Trials of New Drugs
    Sinha, Gunjan
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (03) : 148 - 151
  • [23] How are new drugs disseminated in Japan? Analysis using the National Database of Health Insurance Claims of Japan
    Watanabe, Tomone
    Sugiyama, Takehiro
    Imai, Kenjiro
    Higashi, Takahiro
    [J]. CANCER SCIENCE, 2022, 113 (05) : 1771 - 1778
  • [24] Development of Orphan Drugs in Japan: Effects of a Support System for Development of Orphan Drugs in Japan
    Makoto Shiragami
    Kiyohito Nakai
    [J]. Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 829 - 837
  • [25] Development of orphan drugs in Japan: Effects of a support system for development of orphan drugs in Japan
    Shiragami, M
    Nakai, K
    [J]. DRUG INFORMATION JOURNAL, 2000, 34 (03): : 829 - 837
  • [26] Rationales of delay and difference in regulatory review by Japan, the USA and Europe among new drugs first approved in Japan
    Tanaka, Mototsugu
    Idei, Mayumi
    Sakaguchi, Hiroshi
    Kato, Ryosuke
    Sato, Daisuke
    Sawanobori, Kenji
    Kawarasaki, Shuichi
    Hata, Toshiyuki
    Yoshizaki, Asako
    Nakamura, Miki
    Ikuma, Mutsuhiro
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (08) : 3279 - 3291
  • [27] Exploratory Analysis of Drug Lag in New Oncology Drugs Between Japan and the US
    Akio Maki
    Mamoru Narukawa
    [J]. Therapeutic Innovation & Regulatory Science, 2023, 57 : 671 - 677
  • [28] Exploratory Analysis of Drug Lag in New Oncology Drugs Between Japan and the US
    Maki, Akio
    Narukawa, Mamoru
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (04) : 671 - 677
  • [29] Pharmaceutical Pricing and Reimbursement in Japan: For Faster, More Complete Access to New Drugs
    Takayama, Akane
    Narukawa, Mamoru
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (03) : 361 - 367
  • [30] Pharmaceutical Pricing and Reimbursement in Japan: For Faster, More Complete Access to New Drugs
    Akane Takayama
    Mamoru Narukawa
    [J]. Therapeutic Innovation & Regulatory Science, 2016, 50 : 361 - 367
12345